TGFB1 and systemic sclerosis: Thus, we could propose a role for miR-27a in SSc; it seems likely that miR-27 negatively affects molecular pathways involved in fibrogenesis, such as the TGF-β signaling pathway, and as a result, it could be considered an anti-fibrotic microRNA.